CLEARA

CLEARA is a preclinical-stage biopharmaceutical company focused on developing therapies to treat different types of "senescent" cells. CLEARA's expertise lies in understanding the molecular and biological pathways behind these pathological phenotypes to exploit their vulnerabilities for safe and selective clearance. CLEARA's leading project aims to generate disruptive, innovative, and proprietary technologies to combat "scar cell" senescence, addressing advanced cancer and chronic diseases.